BioMarin Pharmaceutical Inc. (BIT:1BMRN)
46.64
+1.45 (3.21%)
Last updated: Sep 19, 2025, 4:33 PM CET
BioMarin Pharmaceutical Market Cap
BioMarin Pharmaceutical has a market cap or net worth of €8.89 billion as of September 22, 2025. Its market cap has decreased by -42.44% in one year.
Market Cap
8.89B
Enterprise Value
8.18B
Revenue
2.61B
Ranking
n/a
PE Ratio
15.88
Stock Price
€46.64
Market Cap Chart
Since July 23, 1999, BioMarin Pharmaceutical's market cap has increased from 425.62M to 8.89B, an increase of 1,987.97%. That is a compound annual growth rate of 12.31%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 19, 2025 | 8.89B | -26.55% |
Dec 31, 2024 | 12.10B | -26.36% |
Dec 29, 2023 | 16.43B | -8.70% |
Dec 30, 2022 | 18.00B | 26.18% |
Dec 31, 2021 | 14.26B | 9.60% |
Dec 31, 2020 | 13.01B | -3.84% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
UniCredit | 100.59B |
Intesa Sanpaolo | 96.42B |
Enel SpA | 78.68B |
Ferrari | 72.82B |
Assicurazioni Generali | 49.55B |
Eni S.p.A. | 44.84B |
Leonardo S.p.a. | 28.73B |
Poste Italiane | 26.01B |